Patel Sandip I Insider Trading -- Recent SEC Form 4 Transactions
Patel Sandip I (CIK 1843601) reported 8 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-10-16). Recent activity: Buy AKTX (12,100 shares), Buy AKTX (4,313 shares), Buy AKTX (3,866 shares), Buy AKTX (6,186 shares), Buy ATCH (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-16 | Akari Therapeutics Plc (AKTX) | Director | Buy | 12,100 | $95,578 |
| 2026-10-16 | Akari Therapeutics Plc (AKTX) | Director | Buy | 4,313 | $34,068 |
| 2026-10-16 | Akari Therapeutics Plc (AKTX) | Director | Buy | 3,866 | $2 |
| 2026-10-16 | Akari Therapeutics Plc (AKTX) | Director | Buy | 6,186 | $2 |
| 2026-09-28 | AtlasClear Holdings, Inc. (ATCH) | CFO & General Counsel | Buy | 50,000 | $11,000 |
| 2026-09-28 | AtlasClear Holdings, Inc. (ATCH) | CFO & General Counsel | Buy | 50,000 | $10,000 |
| 2026-09-28 | AtlasClear Holdings, Inc. (ATCH) | CFO & General Counsel | Buy | 50,000 | $11,000 |
| 2026-09-28 | AtlasClear Holdings, Inc. (ATCH) | CFO & General Counsel | Buy | 50,000 | $10,000 |
Source: SEC Form 4 filings · as of 2026-10-16